{"nct_id":"NCT05394350","title":"A Study of MK-1088 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-1088-002)","status":"TERMINATED","status_verified_date":"2024-11","start_date":"2022-07-07","start_date_type":"ACTUAL","primary_completion_date":"2023-09-07","primary_completion_date_type":"ACTUAL","completion_date":"2023-09-07","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}